quantisnow
FeedTopReportsPricing
⌘K
Live feed
18:07:30·41d
INSIDERFiling
Warby Parker Inc. logo

Director Raider Jeffrey Jacob sold $635,750 worth of shares (25,000 units at $25.43), decreasing direct ownership by 5% to 448,697 units (SEC Form 4)

WRBY· Warby Parker Inc.
Health Care
Original source

Companies

  • WRBY
    Warby Parker Inc.
    Health Care

Recent analyst ratings

  • Dec 10UpdateCitizens JMP$30.00
  • Nov 7UpdateTelsey Advisory Group$24.00
  • Aug 1UpdateTelsey Advisory Group$28.00
  • Jul 10UpdateCitizens JMP-
  • Apr 30UpdateCitigroup$17.00
  • Apr 17UpdateLoop Capital$27.00

Related

  • INSIDER3d
    SEC Form 4 filed by Blumenthal Neil Harris
  • SEC7d
    SEC Form 144 filed by Warby Parker Inc.
  • PR7d
    Warby Parker to Announce First Quarter 2026 Financial Results on May 7, 2026
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Warby Parker Inc.
  • INSIDER48d
    Co-Chief Executive Officer Blumenthal Neil Harris converted options into 13,475 shares and covered exercise/tax liability with 7,453 shares, increasing direct ownership by 14% to 50,165 units (SEC Form 4)
  • INSIDER48d
    Co-Chief Executive Officer Gilboa David Abraham converted options into 13,475 shares and covered exercise/tax liability with 7,453 shares, increasing direct ownership by 14% to 50,293 units (SEC Form 4)
  • INSIDER48d
    Director Singer Bradley E sold $434,781 worth of shares (15,793 units at $27.53), decreasing direct ownership by 50% to 16,026 units (SEC Form 4)
  • INSIDER50d
    Co-Chief Executive Officer Gilboa David Abraham was granted 15,967 shares and covered exercise/tax liability with 8,943 shares, increasing direct ownership by 19% to 44,271 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022